nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer
|
Fohlin, Helena |
|
2013 |
49 |
6 |
p. 1196-1204 9 p. |
artikel |
2 |
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
|
Sternberg, Cora N. |
|
2013 |
49 |
6 |
p. 1287-1296 10 p. |
artikel |
3 |
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
|
Ferlay, J. |
|
2013 |
49 |
6 |
p. 1374-1403 30 p. |
artikel |
4 |
Cancer rehabilitation indicators for Europe
|
Baili, Paolo |
|
2013 |
49 |
6 |
p. 1356-1364 9 p. |
artikel |
5 |
Childhood acute lymphoblastic leukaemia and birthweight: Insights from a pooled analysis of case–control data from Germany, the United Kingdom and the United States
|
Roman, Eve |
|
2013 |
49 |
6 |
p. 1437-1447 11 p. |
artikel |
6 |
Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
|
Lee, Hee Eun |
|
2013 |
49 |
6 |
p. 1448-1457 10 p. |
artikel |
7 |
Deregulation of protein methylation in melanoma
|
Limm, Katharina |
|
2013 |
49 |
6 |
p. 1305-1313 9 p. |
artikel |
8 |
Description of selected characteristics of familial glioma patients – Results from the Gliogene Consortium
|
Sadetzki, Siegal |
|
2013 |
49 |
6 |
p. 1335-1345 11 p. |
artikel |
9 |
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients
|
Vincenzi, Bruno |
|
2013 |
49 |
6 |
p. 1501-1508 8 p. |
artikel |
10 |
Effects of erlotinib first-line maintenance therapy versus placebo on the health-related quality of life of patients with metastatic non-small-cell lung cancer
|
Juhász, Erzsébet |
|
2013 |
49 |
6 |
p. 1205-1215 11 p. |
artikel |
11 |
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
|
Ducreux, M. |
|
2013 |
49 |
6 |
p. 1236-1245 10 p. |
artikel |
12 |
Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer
|
Therkildsen, Christina |
|
2013 |
49 |
6 |
p. 1226-1235 10 p. |
artikel |
13 |
Gonadal function recovery in very long-term male survivors of childhood cancer
|
van Dorp, Wendy |
|
2013 |
49 |
6 |
p. 1280-1286 7 p. |
artikel |
14 |
High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
|
Flammiger, Anna |
|
2013 |
49 |
6 |
p. 1273-1279 7 p. |
artikel |
15 |
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer
|
Tan, David S.P. |
|
2013 |
49 |
6 |
p. 1246-1253 8 p. |
artikel |
16 |
Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databases
|
Walker, Alex J. |
|
2013 |
49 |
6 |
p. 1404-1413 10 p. |
artikel |
17 |
Interactions between MAP kinase and oestrogen receptor in human breast cancer
|
McGlynn, Liane M. |
|
2013 |
49 |
6 |
p. 1176-1186 11 p. |
artikel |
18 |
Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies
|
van der Rhee, Han |
|
2013 |
49 |
6 |
p. 1422-1436 15 p. |
artikel |
19 |
Local control and sequelae in localised Ewing tumours of the spine: A French retrospective study
|
Vogin, Guillaume |
|
2013 |
49 |
6 |
p. 1314-1323 10 p. |
artikel |
20 |
Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer
|
van der Burg, M.E.L. |
|
2013 |
49 |
6 |
p. 1254-1263 10 p. |
artikel |
21 |
Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome
|
Malouf, Gabriel G. |
|
2013 |
49 |
6 |
p. 1324-1334 11 p. |
artikel |
22 |
Mindfulness significantly reduces self-reported levels of anxiety and depression: Results of a randomised controlled trial among 336 Danish women treated for stage I–III breast cancer
|
Würtzen, Hanne |
|
2013 |
49 |
6 |
p. 1365-1373 9 p. |
artikel |
23 |
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia – Long-term results of trial ALL-REZ BFM P95/96
|
Eckert, Cornelia |
|
2013 |
49 |
6 |
p. 1346-1355 10 p. |
artikel |
24 |
Mothers’ screening histories influence daughters’ vaccination uptake: An analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England
|
Spencer (nee Pilkington), Angela M. |
|
2013 |
49 |
6 |
p. 1264-1272 9 p. |
artikel |
25 |
New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: The role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasome
|
Fratelli, Maddalena |
|
2013 |
49 |
6 |
p. 1491-1500 10 p. |
artikel |
26 |
Outcome of second-line chemotherapy for biliary tract cancer
|
Bridgewater, John |
|
2013 |
49 |
6 |
p. 1511- 1 p. |
artikel |
27 |
Population-based survival of penile cancer patients in Europe and the United States of America: No improvement since 1990
|
Verhoeven, R.H.A. |
|
2013 |
49 |
6 |
p. 1414-1421 8 p. |
artikel |
28 |
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies
|
Licitra, Lisa |
|
2013 |
49 |
6 |
p. 1161-1168 8 p. |
artikel |
29 |
Renal tumours in a Tsc1 +/– mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
|
Yang, Jian |
|
2013 |
49 |
6 |
p. 1479-1490 12 p. |
artikel |
30 |
Resistance to BRAF-targeted therapy in melanoma
|
Sullivan, Ryan J. |
|
2013 |
49 |
6 |
p. 1297-1304 8 p. |
artikel |
31 |
Response to letter ‘Outcome of second-line chemotherapy for biliary tract cancer’
|
Walter, Thomas |
|
2013 |
49 |
6 |
p. 1512-1513 2 p. |
artikel |
32 |
Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer
|
Infante, Jeffrey R. |
|
2013 |
49 |
6 |
p. 1169-1175 7 p. |
artikel |
33 |
Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: Molecular whole-node analysis of all removed nodes
|
Osako, Tomo |
|
2013 |
49 |
6 |
p. 1187-1195 9 p. |
artikel |
34 |
Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years
|
Cufer, Tanja |
|
2013 |
49 |
6 |
p. 1216-1225 10 p. |
artikel |
35 |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai, Yu-Chieh |
|
2013 |
49 |
6 |
p. 1458-1466 9 p. |
artikel |
36 |
Tissue redox activity as a sensing platform for imaging of cancer based on nitroxide redox cycle
|
Zhelev, Zhivko |
|
2013 |
49 |
6 |
p. 1467-1478 12 p. |
artikel |
37 |
Transarterial chemoembolisation is not superior to embolisation alone: The recent European Association for the Study of the Liver (EASL)–European Organisation for Research and Treatment of Cancer (EORTC) guidelines
|
Tsochatzis, Emmanuel |
|
2013 |
49 |
6 |
p. 1509-1510 2 p. |
artikel |